|
Dr. Maxine Gowen is President and Chief Executive Officer of Trevena Inc. a privately held drug discovery company. Prior to joining Trevena Dr. Gowen was Senior Vice President of GlaxoSmithKline’s Center of Excellence for External Drug Discovery. In that position she built and led a new division with a mission to create a drug discovery portfolio through business development alliances with innovative healthcare companies. She was with GSK for 15 years where she held a series of executive management positions in drug discovery and development and led the GSK venture capital subsidiary S.R. One. Before GSK Dr. Gowen was Senior Lecturer and Head Bone Cell Biology Group Department of Bone and Joint Medicine University of Bath U.K. Dr. Gowen has been honored with a number of research awards and prizes has authored more than 125 peer-reviewed publications reviews and book chapters and holds five patents. She received her Ph.D. from the University of Sheffield U.K. an M.B.A. with academic honors from The Wharton School of the University of Pennsylvania and a B.Sc. with Honors in Biochemistry from the University of Bristol U.K.
| 